Aardvark Therapeutics, Inc. Common Stock (AARD) vs TuHURA Biosciences, Inc. (HURA)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and TuHURA Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.09HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
HURA
TuHURA Biosciences, Inc.
$1.90HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — AARD vs HURA
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)HURA -58.9% (-35.9%/yr)HURA compounded faster over this window
AARD HURA
AARD vs HURA: by the numbers
- •HURA is the larger company ($121M vs $111M market cap).
Metrics side by side
Valuation
| Metric | AARD | HURA |
|---|---|---|
| P/B ratio | 1.49 | 6.62 |
Profitability
| Metric | AARD | HURA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -93.44% | -165.57% |
| ROIC | -97.99% | -137.40% |
Growth (annualized)
| Metric | AARD | HURA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -45.49% |
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROETuHURA Biosciences ROEAardvark Therapeutics, Inc. Common Stock operating marginTuHURA Biosciences operating marginAardvark Therapeutics, Inc. Common Stock revenue growthTuHURA Biosciences revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowTuHURA Biosciences free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.